Viewing Study NCT01000623


Ignite Creation Date: 2025-12-18 @ 8:15 AM
Ignite Modification Date: 2025-12-23 @ 11:09 PM
Study NCT ID: NCT01000623
Status: None
Last Update Posted: 2025-01-08 00:00:00
First Post: 2009-10-19 00:00:00
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: Venlafaxine and Hypnosis or Focused Attention in Treating Patients with Hot Flashes
Sponsor: None
Organization:

Study Overview

Official Title: Evaluation of a Biobehavioral Intervention for Hot Flashes
Status: None
Status Verified Date: 2025-01
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Objectives:

I. To evaluate the effect of hypnosis plus venlafaxine versus focused attention with venlafaxine versus hypnosis plus a placebo versus focused attention plus a placebo for reducing hot flashes.

II. To evaluate the side effects associated with hypnosis with venlafaxine versus focused attention with venlafaxine versus hypnosis plus a placebo versus focused attention plus a placebo for reducing hot flashes.

III. To evaluate the effects of the four treatment arms on mood, sleep, hot flash interference and menopause quality of life.

IV. To explore the role of expectancy and hypnotizability as moderators of the effect of each of the four treatment arms in reducing hot flashes.

Outline: Patients are randomized to 1 of 4 intervention arms. Patients receive oral venlafaxine or a placebo and practice hypnosis or focused attention.
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: